Extract from the Register of European Patents

EP Citations: EP3236966

Cited inSearch
Type:Patent literature
Publication No.:WO2009006389  [XI]
 (SUNESIS PHARMACEUTICALS INC et al.) [X] 1-3,7-9,15 * abstract * * page 48, paragraph 126 - page 49, paragraph 127 * * page 168; compound 10Da * * claims 1-30 *[I] 4-6,10-14
Type:Patent literature
Publication No.:WO2010064722  [X]
 (TAKEDA PHARMACEUTICAL et al.) [X] 1-7,15 * abstract * * page 77, line 1 - page 79, line 2; example 53; claims 1,18,24-26 *
Type:Non-patent literature
Publication information:[XP]   "A Phase 1B Study of MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic Malignancies", 30 December 2014 (2014-12-30), XP002784013, Retrieved from the Internet [retrieved on 20180820] [XP] 1-15 * the whole document *
Type:Non-patent literature
Publication information:[XI]   BALANI S K ET AL: "Drug drug interaction predictions for MLN2480, an investigational pan-RAF inhibitor, based on nonclinical data", EUROPEAN JOURNAL OF CANCER, vol. 50, no. Suppl. 6, November 2014 (2014-11-01), & 26TH EORTC-NCI-AACR SYMPOSIUM ON MOLECULAR TARGETS AND CANCER THERAPEUTICS; BARCELONA, SPAIN; NOVEMBER 18 -21, 2014, pages 54 - 55, XP002784014, ISSN: 0959-8049 [X] 1-3,7-9,15 * Abstract 162 *[I] 4-6,10-14
Type:Non-patent literature
Publication information:[A]   MASANORI OKANIWA ET AL: "Discovery of a Selective Kinase Inhibitor (TAK-632) Targeting Pan-RAF Inhibition: Design, Synthesis, and Biological Evaluation of C -7-Substituted 1,3-Benzothiazole Derivatives", JOURNAL OF MEDICINAL CHEMISTRY, vol. 56, no. 16, 1 August 2013 (2013-08-01), pages 6478 - 6494, XP055500984, ISSN: 0022-2623, DOI: 10.1021/jm400778d [A] 1-7,15 * the whole document *
DOI: http://dx.doi.org/10.1021/jm400778d
Cited inInternational search
Type:Patent literature
Publication No.:US2010183600  [XY]
 (LAPIERRE JEAN-MARC et al.) [X] 1, 2, 17 * entire document *[Y] 3, 10-15, 18
Type:Patent literature
Publication No.:WO2013144923  [Y]
 (TAKEDA PHARMACEUTICAL et al.) [Y] 3, 10-15, 18 * entire document *
Type:Patent literature
Publication No.:US2012214828  [Y]
 (HATZIVASSILIOU GEORGIA et al.) [Y] 11-13 * entire document *
Type:Patent literature
Publication No.:WO2009018238  [Y]
 (ARDEA BIOSCIENCES INC et al.) [Y] 14, 15 * entire document *
Type:Patent literature
Publication No.:WO2015148828  [P, X]
 (MILLENNIUM PHARM INC et al.) [P, X] 1-3, 10-15, 17, 18 * entire document *